CEEMEA

The Rohatyn Group Completes Its Investment in Amethyst Radiotherapy, A Leading Operator of Oncology Radiotherapy Clinics Across Europe

New York, NY, November 5, 2019 –  The Rohatyn Group (“TRG”), an emerging markets focused asset management firm, today announced an investment in Amethyst Radiotherapy (“Amethyst” or the “Company”), obtaining co-control of the Company alongside the two co-founders. Amethyst is one of the largest operators of…